These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 7990682)
21. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution. Jallad RS; Musolino NR; Salgado LR; Bronstein MD Clin Endocrinol (Oxf); 2005 Aug; 63(2):168-75. PubMed ID: 16060910 [TBL] [Abstract][Full Text] [Related]
22. [Sulpiride and TRH loading tests in acromegaly]. Zséli J; Földes J; Holló I; Kollin E; Horváth C; Gács G; Borvendég J Orv Hetil; 1980 Oct; 121(42):2569-72. PubMed ID: 6780963 [No Abstract] [Full Text] [Related]
23. Thyrotropin secretion during oral glucose tolerance test in acromegalic patients and control subjects. Hubina E; Kovács L; Görömbey Z; Szabolcs I; Czirják S; Góth MI Endocrine; 2003 Nov; 22(2):177-80. PubMed ID: 14665723 [TBL] [Abstract][Full Text] [Related]
24. [Determination of growth hormone response to thyreoliberin in the evaluation of lisuride therapy of acromegaly]. Felt V; Nedvídková J Vnitr Lek; 1982 Aug; 28(8):756-61. PubMed ID: 6814061 [No Abstract] [Full Text] [Related]
25. [Growth hormone liberation after TRH in patients with acromegaly]. Morosini PP; Campanella N; Carletti P; Sturbini S; Testa I Boll Soc Ital Biol Sper; 1980 Jun; 56(12):1239-42. PubMed ID: 6779828 [No Abstract] [Full Text] [Related]
26. [Study of acromegalic activity using TRH and glucose tolerance test (author's transl)]. Santelices R; Cáceres E; Schachter D; Majlis S; Pineda G Rev Med Chil; 1979 Dec; 107(12):1099-102. PubMed ID: 121782 [No Abstract] [Full Text] [Related]
27. Postoperative prognostic indicators of control of acromegaly. Yamada S; Aiba T; Shishiba Y Surg Neurol; 1989 Jan; 31(1):14-9. PubMed ID: 2645670 [TBL] [Abstract][Full Text] [Related]
28. Postglucose growth hormone nadir and insulin-like growth factor-1 in naïve-active acromegalic patients: do these parameters always correlate? Ribeiro-Oliveira A; Faje A; Barkan A Arq Bras Endocrinol Metabol; 2011 Oct; 55(7):494-7. PubMed ID: 22147100 [No Abstract] [Full Text] [Related]
30. [Acromegaly]. von Werder K Fortschr Med; 1980 Aug; 98(32):1202-5. PubMed ID: 6773866 [No Abstract] [Full Text] [Related]
31. Evaluation of disease activity by IGF-I and IGF binding protein-3 (IGFBP3) in acromegaly patients distributed according to a clinical score. Jasper H; Pennisi P; Vitale M; Mella A; Ropelato G; Chervin A J Endocrinol Invest; 1999 Jan; 22(1):29-34. PubMed ID: 10090134 [TBL] [Abstract][Full Text] [Related]
32. Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly. Wass JA J Endocrinol; 1997 Oct; 155 Suppl 1():S17-9; discussion S21. PubMed ID: 9389991 [TBL] [Abstract][Full Text] [Related]
33. Biochemical evidence supporting the Cortina criteria. von Werder K J Endocrinol Invest; 2005; 28(11 Suppl International):81-3. PubMed ID: 16625853 [TBL] [Abstract][Full Text] [Related]
34. Biochemical markers of acromegalic activity. Jasper H; Chervin A; Vitale M; Mella A; Ropelato G; Basso A Medicina (B Aires); 1994; 54(1):25-30. PubMed ID: 7990682 [TBL] [Abstract][Full Text] [Related]
35. Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system. Minuto F; Resmini E; Boschetti M; Arvigo M; Sormani MP; Giusti M; Ferone D; Barreca A Clin Endocrinol (Oxf); 2004 Jul; 61(1):138-44. PubMed ID: 15212656 [TBL] [Abstract][Full Text] [Related]
36. Are there alternative tests for diagnosis of acromegaly? Popovic V J Endocrinol Invest; 2005; 28(11 Suppl International):73-4. PubMed ID: 16625850 [TBL] [Abstract][Full Text] [Related]